首頁 > 市場調查報告書 > 醫療設備

美容整形

北美神經毒素市場預測至 2028 年 - COVID-19 影響和區域分析 - 按產品類型、應用和最終用戶

市場調查報告書

商品編碼

1375139

北美神經毒素市場預測至 2028 年 - COVID-19 影響和區域分析 - 按產品類型、應用和最終用戶

North America Neurotoxins Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Application, and End User

出版日期: 2023年08月24日 | 出版商:

The Insight Partners | 英文 99 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

北美神經毒素市場預計將從2023年的48.0129億美元成長到2028年的84.1695億美元。預計2023年至2028年年複合成長率為11.9%。

創新臉部美容產品的出現推動了北美神經毒素市場

預計神經毒素的整體市場將在預測期內呈指數級成長，以滿足日益成長的臉部美容需求。 2022年3月，Aquavit Pharmaceuticals, Inc.宣布提交「DTX-021」的研究新藥（IND），這是一種A型肉毒桿菌毒素，旨在治療中度至重度眉間紋。本產品是一種高度純化且經過臨床測試的可注射神經調節劑，含有源自肉毒桿菌產生的神經毒素的 900 kDa 蛋白質複合物。此外，Aquavit 正在透過推出 DTX-022 加速臨床試驗，其最終批准將被認為是首個、也是世界上第一個全臉部微注射神經毒素的產品。同樣，隨著減重趨勢的持續，胃肉毒桿菌已成為尋求非侵入性手術的患者的熱門選擇。它涉及使用內視鏡技術將肉毒桿菌注射到特定的胃部區域。透過這種技術，可以抑制胃部肌肉的收縮。由於這種限制，胃的排空過程需要更長的時間，這導致患者長時間感到飽腹感，導致食慾下降並改善與體重相關的健康問題/生活方式障礙，例如高血壓和糖尿病。因此，創新臉部美容產品的出現有助於北美神經毒素市場的成長。

北美神經毒素市場概況

北美神經毒素市場分為美國、加拿大和墨西哥。美國是最大且成長最快的神經毒素市場。該地區的市場成長歸因於產品推出的增加、FDA 對用於各種肌肉疾病的神經毒素的批准不斷增加、人口老齡化、非手術或微創美容手術數量的增加、美容手術數量的增加以及對神經毒素的需求不斷成長微創治療。

北美神經毒素市場收入及 2028 年預測（百萬美元）

北美神經毒素市場細分

北美神經毒素市場按產品類型、應用、最終用戶和國家細分。根據產品類型，北美神經毒素市場細分為肉毒桿菌、dysport、xenomin 等。肉毒桿菌細分市場在 2023 年佔據最大的市場佔有率。

根據應用，北美神經毒素市場分為治療和美容市場。 2023 年，治療領域佔據更大的市場佔有率。

根據最終用戶，北美神經毒素市場分為醫院、專科診所、皮膚科診所等。 2023 年，醫院細分市場佔據最大市場佔有率。

根據國家/地區，北美神經毒素市場分為美國、加拿大和墨西哥。 2023 年，美國佔據市場佔有率主導地位。

AbbVie Inc、Hugel Inc、Ipsen SA、Meditox Inc、Merz Pharma GmbH & Co KGaA、Metabiologics 和 Revance Therapeutics Inc 是北美神經毒素市場的領導公司。

The overall market for neurotoxins is expected to propel exponentially during the forecast period to meet the growing demand for facial aesthetics. In March 2022, Aquavit Pharmaceuticals, Inc. announced the submission of an Investigational New Drug (IND) of "DTX-021"-a botulinum toxin type A intended to treat moderate to severe glabellar lines. The product is a highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. Also, Aquavit is accelerating clinical trials by introducing DTX-022, and its final approval will be recognized as the first-of-its-kind and the world's first pan-facial microinjection of neurotoxins. Likewise, with the ongoing weight loss trend, Gastric Botox has become a popular choice among patients seeking non-invasive procedures. It involves injecting Botox into specific stomach regions using an endoscopic technique. By this technique, the contraction of the stomach muscles is restrained. Due to the limitation, the stomach's evacuation process takes longer, which causes the patient to feel full for longer period, resulting in reduced appetite and improved weight-related health issues/lifestyle disorders such as high blood pressure and diabetes mellitus. Therefore, emergence of innovative facial aesthetic products helps the North America neurotoxin market to grow.

North America Neurotoxins Market Overview

The North America neurotoxin market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for neurotoxins. The market growth in the region is attributed to the increasing product launches, growing FDA approvals for neurotoxins for various muscular conditions, rising aging population, increasing numbers of non-surgical or minimally invasive cosmetic procedures, increasing number of aesthetic procedures, and growing demand for minimally invasive therapeutics.

North America Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)

North America Neurotoxins Market Segmentation

The North America neurotoxins market is segmented into product type, application, end user, and country. Based on product type, the North America neurotoxins market is sub segmented into botox, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.

Based on application, the North America neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.

Based on end user, the North America neurotoxins market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.

Based on country, the North America neurotoxins market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2023.

AbbVie Inc, Hugel Inc, Ipsen SA, Medytox Inc, Merz Pharma GmbH & Co KGaA, Metabiologics, and Revance Therapeutics Inc are among the leading companies operating in the North America neurotoxins market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America neurotoxins market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America neurotoxins market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the neurotoxins market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Neurotoxin Market - by Type
- 1.3.2 North America Neurotoxin Market - by Application
- 1.3.3 North America Neurotoxin Market - by End User
- 1.3.4 North America Neurotoxin Market - by Country

2. North America Neurotoxin Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Neurotoxin Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion

5. North America Neurotoxin Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Surge in Cosmetic Procedures to Improve Appearance
- 5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
- 5.2.1 Improper/Inappropriate Injection Technique
5.3 Market Opportunities
- 5.3.1 Neurotoxins to Reduce Spasticity in Upper Limb Muscles
5.4 Future Trends
- 5.4.1 BOTA for Assisted Reproductive Technology (ART)
5.5 Impact Analysis

6. North America Neurotoxin Market

6.1 North America Neurotoxin Market Revenue Forecast and Analysis

7. North America Neurotoxin Market - Revenue and Forecast to 2028 - By Type

7.1 Overview
7.2 North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
- 7.3.1 Overview
- 7.3.2 Botox: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
- 7.4.1 Overview
- 7.4.2 Dysport: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
- 7.5.1 Overview
- 7.5.2 Xeomin: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Neurotoxin Market - Revenue and Forecast to 2028 - By Application

8.1 Overview
8.2 North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
- 8.3.1 Overview
- 8.3.2 Therapeutic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
- 8.4.1 Overview
- 8.4.2 Aesthetic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Neurotoxin Market - Revenue and Forecast to 2028 - By End User

9.1 Overview
9.2 North America Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
- 9.3.1 Overview
- 9.3.2 Hospitals: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
- 9.4.1 Overview
- 9.4.2 Medical Spas and Beauty Centers: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
- 9.5.1 Overview
- 9.5.2 Dermatology Clinics: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Neurotoxin Market -Revenue and Forecast to 2028- Country Analysis

10.1 Overview
- 10.1.1 North America: Neurotoxin Market, by Country, 2022& 2028 (%)
  - 10.1.1.1 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.1.4 US: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.1.5 US: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Canada: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Canada: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.3 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: Neurotoxin Market, by End User, 2020-2028 (US$ Million)

11. North America Neurotoxins Market-Industry Landscape

11.1 Overview
11.2 Organic Growth Strategies
- 11.2.1 Overview
11.3 Inorganic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 Merz Pharma GmbH & Co KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 AbbVie Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Revance Therapeutics Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Ipsen SA
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Medytox Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Hugel Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Metabiologics
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. North America Neurotoxins Market - Revenue and Forecast to 2028 (US$ Million)
Table 2. US Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 3. US Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. US Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Neurotoxin Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico: Neurotoxin Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 10. Mexico: Neurotoxin Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 11. Recent Organic Growth Strategies in Neurotoxins Market
Table 12. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 13. Glossary of Terms

List Of Figures

Figure 1. North America Neurotoxin Market Segmentation
Figure 2. North America Neurotoxin Market by Country
Figure 3. North America Neurotoxin Market Overview
Figure 4. North America Neurotoxin Market, By Type
Figure 5. North America Neurotoxin Market, By Country
Figure 6. North America: PEST Analysis
Figure 7. North America Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 8. North America Neurotoxin Market - Revenue Forecast and Analysis - 2021-2028
Figure 9. North America Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 10. Botox: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 11. Dysport: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Xeomin: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. North America Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 15. Therapeutic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Aesthetic: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. North America Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 18. Hospitals: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Medical Spas and Beauty Centers: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dermatology Clinics: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: North America Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. North America: Neurotoxin Market, by Key Country - Revenue (2022) (US$ Million)
Figure 23. North America: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 24. US: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Canada: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Mexico: Neurotoxin Market - Revenue and Forecast to 2028 (US$ Million)